Literature DB >> 869360

Perspectives in the treatment of breast cancer: 1976.

.   

Abstract

Breast cancer is the major cancer killer of women in the United States. Recent advances in therapy promise more effective control of this illness. The development of hormone receptor analysis permits us to better understand the mechanisms of action of steroid and peptide hormones and increases the likelihood of using there hormonal agents effectively. Prospective surgical and surgical adjuvant trials offer the opportunity to define accurately the appropriate surgical procedure and most effective postoperative therapy after initial surgery. The development of chemotherapy, first singly and now in combination, has led to improved treatment of patients with advanced disease and defined better chemotherapy for use in adjuvant settings. The investigation of a matrix of marker substances in breast cancer may uncover new methods to assess residual disease and to monitor disease recurrence.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869360     DOI: 10.7326/0003-4819-86-6-784

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03

2.  Autologous bone marrow transplantation in metastatic breast cancer.

Authors:  P S Stewart
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

3.  Phase II study of amonafide in advanced breast cancer.

Authors:  W Scheithauer; C Dittrich; G Kornek; K Haider; W Linkesch; H Gisslinger; D Depisch
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.